Central Texas Angel Network — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Savarasavarapharma.cominNASDAQ: SVRADec 2019
Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases.
BiotechHealthtechMedical DevicesAustin, US
Matt Pauls(Chair of the Board of Directors and Chief Executive Officer)Richard J. Hawkins(Director)An van Es-Johansson(Director)Ricky Sun(Director)Taneli Jouhikainen(Executive Officer)Mike Ciesla(Executive Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.